Medical Research Council

The Medical Research Council (the MRC) is a publicly-funded agency responsible for co-ordinating and funding medical research in the United Kingdom. It is one of seven Research Councils in the UK and is answerable to, although politically independent from, the Department for Business, Innovation and Skills. It is dedicated to "improving human health through world-class medical research". The MRC focuses on high-impact research and has provided the financial support and scientific expertise behind a number of medical breakthroughs, including the development of penicillin and the discovery of the structure of DNA. Research funded by the MRC has produced 29 Nobel Prize winners to date. The MRC was founded as the Medical Research Committee and Advisory Council in 1913, with its prime role being the distribution of medical research funds under the terms of the National Insurance Act 1911. This was a consequence of the recommendation of the Royal Commission on Tuberculosis, which recommended the creation of a permanent medical research body. The mandate was not limited to tuberculosis, however.

Website
http://www.mrc.ac.uk
Wikipedia
http://en.wikipedia.org/wiki/Medical_Research_Council

Some content from Wikipedia, licensed under CC BY-SA

Subscribe to rss feed

Medical research

Fully functional immune organ grown in mice from lab-created cells

Scientists have for the first time grown a complex, fully functional organ from scratch in a living animal by transplanting cells that were originally created in a laboratory. The advance could in future aid the development ...

Neuroscience

New study discovers how neurons die in Alzheimer's disease

A research team has finally discovered how neurons die in Alzheimer's disease (AD). The team is led by Professor Bart De Strooper at VIB-KU Leuven and the UK Dementia Research Institute (UK DRI) at UCL and Dr. Sriram Balusu ...

Medical research

New approach to tackle Ebola and other deadly infections

Medical Research Council scientists have isolated therapeutic antibodies from healthy volunteers exposed to the Ebola vaccine but not Ebola virus itself, suggesting that protective therapies could be developed from people ...

page 1 from 9